To determine if the effects of Gata4 on tumor suppression were dose-dependent, we generated mixed populations with the following percentages of tet-Gata4 cells, with the remaining cells being tet-GFP: 33%, 15%, and 1% (Fig. 4b). Here, GATA4 is linked to neoplasm.